Four hundred and nineteen patients with stage I-IV CRCs were screened for RTL of cancer (cRTL) and histologically normal adjacent mucosa (nRTL), MSI, and mutations in KRAS, BRAF, PIK3CA and TP53. CIMP status was analyzed in 382 cancers. This evidence concerns the gene PIK3CA and cancer.